{
    "doc_id": "v1_data/Qwen2.5-32B-Instruct_gpqa-diamond_responses_20.json",
    "metadata": {
        "model_id": "Qwen/Qwen2.5-32B-Instruct",
        "correct_answer": "D"
    },
    "raw_text": {
        "question": "Compounds that have the same molecular formula but are different in their structural arrangement are known as isomers. Isomers have two types, constitutional isomers and stereoisomers. Constitutional isomers have the same molecular formula but differ in their structures. In stereoisomers, molecules are connected in the same way, but their arrangements in space are different.\nAmong the given compounds (benzoquinone & cyclohexane-1,3,5-trione) the compound that does not show tautomerism (A) and among methyl 2-hydroxypropanoate and dimethyl fumarate which one will show optical isomerism (B).\nA. A = cyclohexane-1,3,5-trione, B = methyl 2-hydroxypropanoate\nB. A = benzoquinone, B = dimethyl fumarate\nC. A = cyclohexane-1,3,5-trione, B = dimethyl fumarate\nD. A = benzoquinone, B = methyl 2-hydroxypropanoate",
        "response": "To solve this problem, we need to understand the concepts of tautomerism and optical isomerism.\n\n**Tautomerism** refers to the phenomenon where a molecule can exist in two or more structural forms that are interconvertible by the migration of an atom or a group from one position to another within the molecule, often involving the exchange of a hydrogen atom and a double bond. \n\n**Optical isomerism**, on the other hand, occurs when a molecule has a chiral center (an atom, usually carbon, bonded to four different groups), leading to non-superimposable mirror images (enantiomers).\n\nLet's analyze each part of the question:\n\n### Part A: Tautomerism\n\n- **Benzoquinone**: This compound does not exhibit tautomerism because it lacks the necessary functional groups (like -OH and >C=O) that can undergo tautomerization through the movement of a proton.\n  \n- **Cyclohexane-1,3,5-trione**: This compound can exhibit tautomerism due to the presence of multiple ketone groups (-CO-) which can potentially shift protons between them, forming different tautomers.\n\nTherefore, **benzoquinone** does not show tautomerism.\n\n### Part B: Optical Isomerism\n\n- **Methyl 2-hydroxypropanoate**: This compound contains a chiral center at the second carbon atom (where the hydroxyl group is attached). Therefore, it can exhibit optical isomerism.\n  \n- **Dimethyl fumarate**: Fumarate itself is a geometric isomer of maleate and does not contain a chiral center. Thus, dimethyl fumarate does not exhibit optical isomerism.\n\nTherefore, **methyl 2-hydroxypropanoate** shows optical isomerism.\n\nBased on these analyses, the correct answer is:\n\n**D. A = benzoquinone, B = methyl 2-hydroxypropanoate**"
    },
    "nodes": [
        {
            "id": "ctx0",
            "annotation": false,
            "start": 0,
            "end": 119,
            "label": "context",
            "text": "Compounds that have the same molecular formula but are different in their structural arrangement are known as isomers. ",
            "source": "question"
        },
        {
            "id": "ctx1",
            "annotation": false,
            "start": 119,
            "end": 185,
            "label": "context",
            "text": "Isomers have two types, constitutional isomers and stereoisomers. ",
            "source": "question"
        },
        {
            "id": "ctx2",
            "annotation": false,
            "start": 185,
            "end": 272,
            "label": "context",
            "text": "Constitutional isomers have the same molecular formula but differ in their structures. ",
            "source": "question"
        },
        {
            "id": "ctx3",
            "annotation": false,
            "start": 272,
            "end": 378,
            "label": "context",
            "text": "In stereoisomers, molecules are connected in the same way, but their arrangements in space are different.\n",
            "source": "question"
        },
        {
            "id": "ctx4",
            "annotation": false,
            "start": 378,
            "end": 596,
            "label": "context",
            "text": "Among the given compounds (benzoquinone & cyclohexane-1,3,5-trione) the compound that does not show tautomerism (A) and among methyl 2-hydroxypropanoate and dimethyl fumarate which one will show optical isomerism (B).\n",
            "source": "question"
        },
        {
            "id": "ctx5",
            "annotation": false,
            "start": 596,
            "end": 599,
            "label": "context",
            "text": "A. ",
            "source": "question"
        },
        {
            "id": "ctx6",
            "annotation": false,
            "start": 599,
            "end": 663,
            "label": "context",
            "text": "A = cyclohexane-1,3,5-trione, B = methyl 2-hydroxypropanoate\nB. ",
            "source": "question"
        },
        {
            "id": "ctx7",
            "annotation": false,
            "start": 663,
            "end": 809,
            "label": "context",
            "text": "A = benzoquinone, B = dimethyl fumarate\nC. A = cyclohexane-1,3,5-trione, B = dimethyl fumarate\nD. A = benzoquinone, B = methyl 2-hydroxypropanoate",
            "source": "question"
        },
        {
            "id": "resp0",
            "annotation": false,
            "start": 0,
            "end": 97,
            "label": "planning",
            "text": "To solve this problem, we need to understand the concepts of tautomerism and optical isomerism.\n\n",
            "source": "response"
        },
        {
            "id": "resp1",
            "annotation": false,
            "start": 97,
            "end": 381,
            "label": "fact",
            "text": "**Tautomerism** refers to the phenomenon where a molecule can exist in two or more structural forms that are interconvertible by the migration of an atom or a group from one position to another within the molecule, often involving the exchange of a hydrogen atom and a double bond. \n\n",
            "source": "response"
        },
        {
            "id": "resp2",
            "annotation": false,
            "start": 381,
            "end": 586,
            "label": "fact",
            "text": "**Optical isomerism**, on the other hand, occurs when a molecule has a chiral center (an atom, usually carbon, bonded to four different groups), leading to non-superimposable mirror images (enantiomers).\n\n",
            "source": "response"
        },
        {
            "id": "resp3",
            "annotation": false,
            "start": 586,
            "end": 628,
            "label": "planning",
            "text": "Let's analyze each part of the question:\n\n",
            "source": "response"
        },
        {
            "id": "resp4",
            "annotation": false,
            "start": 628,
            "end": 653,
            "label": "planning",
            "text": "### Part A: Tautomerism\n\n",
            "source": "response"
        },
        {
            "id": "resp5",
            "annotation": false,
            "start": 653,
            "end": 855,
            "label": "reasoning",
            "text": "- **Benzoquinone**: This compound does not exhibit tautomerism because it lacks the necessary functional groups (like -OH and >C=O) that can undergo tautomerization through the movement of a proton.\n  \n",
            "source": "response"
        },
        {
            "id": "resp6",
            "annotation": false,
            "start": 855,
            "end": 1058,
            "label": "reasoning",
            "text": "- **Cyclohexane-1,3,5-trione**: This compound can exhibit tautomerism due to the presence of multiple ketone groups (-CO-) which can potentially shift protons between them, forming different tautomers.\n\n",
            "source": "response"
        },
        {
            "id": "resp7",
            "annotation": false,
            "start": 1058,
            "end": 1114,
            "label": "reasoning",
            "text": "Therefore, **benzoquinone** does not show tautomerism.\n\n",
            "source": "response"
        },
        {
            "id": "resp8",
            "annotation": false,
            "start": 1114,
            "end": 1145,
            "label": "planning",
            "text": "### Part B: Optical Isomerism\n\n",
            "source": "response"
        },
        {
            "id": "resp9",
            "annotation": false,
            "start": 1145,
            "end": 1332,
            "label": "reasoning",
            "text": "- **Methyl 2-hydroxypropanoate**: This compound contains a chiral center at the second carbon atom (where the hydroxyl group is attached). Therefore, it can exhibit optical isomerism.\n  \n",
            "source": "response"
        },
        {
            "id": "resp10",
            "annotation": false,
            "start": 1332,
            "end": 1505,
            "label": "reasoning",
            "text": "- **Dimethyl fumarate**: Fumarate itself is a geometric isomer of maleate and does not contain a chiral center. Thus, dimethyl fumarate does not exhibit optical isomerism.\n\n",
            "source": "response"
        },
        {
            "id": "resp11",
            "annotation": false,
            "start": 1505,
            "end": 1573,
            "label": "reasoning",
            "text": "Therefore, **methyl 2-hydroxypropanoate** shows optical isomerism.\n\n",
            "source": "response"
        },
        {
            "id": "resp12",
            "annotation": false,
            "start": 1573,
            "end": 1622,
            "label": "planning",
            "text": "Based on these analyses, the correct answer is:\n\n",
            "source": "response"
        },
        {
            "id": "resp13",
            "annotation": false,
            "start": 1622,
            "end": 1677,
            "label": "conclusion",
            "text": "**D. A = benzoquinone, B = methyl 2-hydroxypropanoate**",
            "source": "response"
        }
    ],
    "edges": [
        {
            "id": "e0",
            "from_node_id": "ctx1",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e1",
            "from_node_id": "ctx2",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e2",
            "from_node_id": "ctx3",
            "to_node_id": "resp0",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e3",
            "from_node_id": "resp0",
            "to_node_id": "resp1",
            "label": "reason:plan-step"
        },
        {
            "id": "e4",
            "from_node_id": "resp0",
            "to_node_id": "resp2",
            "label": "reason:plan-step"
        },
        {
            "id": "e5",
            "from_node_id": "resp0",
            "to_node_id": "resp3",
            "label": "plan:plan-subplan"
        },
        {
            "id": "e6",
            "from_node_id": "resp3",
            "to_node_id": "resp4",
            "label": "plan:plan-subplan"
        },
        {
            "id": "e7",
            "from_node_id": "resp1",
            "to_node_id": "resp5",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e8",
            "from_node_id": "resp4",
            "to_node_id": "resp5",
            "label": "reason:plan-step"
        },
        {
            "id": "e9",
            "from_node_id": "resp1",
            "to_node_id": "resp6",
            "label": "reason:concept-example"
        },
        {
            "id": "e10",
            "from_node_id": "resp4",
            "to_node_id": "resp6",
            "label": "reason:plan-step"
        },
        {
            "id": "e11",
            "from_node_id": "resp4",
            "to_node_id": "resp7",
            "label": "reason:plan-step"
        },
        {
            "id": "e12",
            "from_node_id": "resp5",
            "to_node_id": "resp7",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e13",
            "from_node_id": "resp3",
            "to_node_id": "resp8",
            "label": "plan:plan-subplan"
        },
        {
            "id": "e14",
            "from_node_id": "resp2",
            "to_node_id": "resp9",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e15",
            "from_node_id": "resp8",
            "to_node_id": "resp9",
            "label": "reason:plan-step"
        },
        {
            "id": "e16",
            "from_node_id": "resp2",
            "to_node_id": "resp10",
            "label": "reason:concept-example"
        },
        {
            "id": "e17",
            "from_node_id": "resp8",
            "to_node_id": "resp10",
            "label": "reason:plan-step"
        },
        {
            "id": "e18",
            "from_node_id": "resp9",
            "to_node_id": "resp10",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e19",
            "from_node_id": "resp2",
            "to_node_id": "resp11",
            "label": "reason:concept-example"
        },
        {
            "id": "e20",
            "from_node_id": "resp9",
            "to_node_id": "resp11",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e21",
            "from_node_id": "resp7",
            "to_node_id": "resp12",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e22",
            "from_node_id": "resp11",
            "to_node_id": "resp12",
            "label": "plan:frontier-plan"
        },
        {
            "id": "e23",
            "from_node_id": "resp7",
            "to_node_id": "resp13",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e24",
            "from_node_id": "resp11",
            "to_node_id": "resp13",
            "label": "reason:premise-conclusion"
        },
        {
            "id": "e25",
            "from_node_id": "resp12",
            "to_node_id": "resp13",
            "label": "reason:stmt-restatement"
        }
    ]
}